PHS
GH icon

PFM Health Sciences’s Guardant Health GH Stock Holding History

PFM Health Sciences’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Buy
+36,701
New +$3.99M 0.47% 66
2021
Q4 		– Sell
-84,455
Closed -$10.6M – 80
2021
Q3 		$10.6M Sell
84,455
-289,676
-77% -$34.4M 0.31% 60
2021
Q2 		$46.5M Buy
374,131
+169,787
+83% +$22.8M 1.46% 25
2021
Q1 		$31.2M Sell
204,344
-23,532
-10% -$3.56M 0.95% 42
2020
Q4 		$29.4M Buy
+227,876
New +$26.2M 1.03% 37

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

PFM Health Sciences's GH Position: Q2 2026 in Review

PFM Health Sciences opened a new position in Guardant Health (GH) in Q2 2026: 36,701 shares worth $5.51M. The stake represents 0.47% of the portfolio and ranks #66 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in GH as recently as Q3 2021.

PFM Health Sciences first reported a position in GH in Q4 2020 and has held it in 5 quarters since. The position peaked at $46.5M in Q2 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • PFM Health Sciences held 36,701 shares of Guardant Health worth $5.51M as of Q2 2026.
  • Guardant Health was a new PFM Health Sciences position in Q2 2026.
  • Guardant Health made up 0.47% of PFM Health Sciences's portfolio in Q2 2026, its #66 holding.
  • PFM Health Sciences first reported a position in Guardant Health in Q4 2020 and has held it in 5 quarters since.
  • PFM Health Sciences's Guardant Health position peaked at $46.5M in Q2 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.